Michael Pepoy

1.5k total citations · 1 hit paper
9 papers, 1.1k citations indexed

About

Michael Pepoy is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Clinical Biochemistry. According to data from OpenAlex, Michael Pepoy has authored 9 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cardiology and Cardiovascular Medicine, 3 papers in Pharmacology and 3 papers in Clinical Biochemistry. Recurrent topics in Michael Pepoy's work include Nitric Oxide and Endothelin Effects (3 papers), Paraoxonase enzyme and polymorphisms (3 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers). Michael Pepoy is often cited by papers focused on Nitric Oxide and Endothelin Effects (3 papers), Paraoxonase enzyme and polymorphisms (3 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers). Michael Pepoy collaborates with scholars based in United States and Pakistan. Michael Pepoy's co-authors include Frederick Van Lente, Marie‐Luise Brennan, Vijay Nambi, Marlene Goormastic, Steven E. Nissen, Ronnier J. Aviles, Stanley L. Hazen, Marc S. Penn, Eric J. Topol and Ellen McErlean and has published in prestigious journals such as New England Journal of Medicine, Arteriosclerosis Thrombosis and Vascular Biology and Clinical Chemistry.

In The Last Decade

Michael Pepoy

9 papers receiving 1.1k citations

Hit Papers

Prognostic Value of Myeloperoxidase in Patients with Ches... 2003 2026 2010 2018 2003 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Pepoy United States 9 422 388 205 197 159 9 1.1k
Stanley L. Hazen United States 6 427 1.0× 335 0.9× 164 0.8× 252 1.3× 68 0.4× 10 1.0k
Edward Black United Kingdom 14 255 0.6× 305 0.8× 322 1.6× 476 2.4× 70 0.4× 28 1.3k
Hiroshi Mokuno Japan 25 369 0.9× 465 1.2× 576 2.8× 162 0.8× 85 0.5× 55 1.7k
Mark Donahue United States 21 369 0.9× 683 1.8× 235 1.1× 186 0.9× 38 0.2× 38 1.6k
Burak Pamukçu Türkiye 21 290 0.7× 682 1.8× 213 1.0× 119 0.6× 25 0.2× 45 1.4k
Toru Shinzato Japan 21 218 0.5× 115 0.3× 203 1.0× 206 1.0× 419 2.6× 48 1.7k
Elena Maggi Italy 13 325 0.8× 151 0.4× 175 0.9× 72 0.4× 122 0.8× 14 990
Yoshiaki Tsukamoto Japan 10 337 0.8× 146 0.4× 303 1.5× 68 0.3× 33 0.2× 14 823
Ellen McErlean United States 16 465 1.1× 919 2.4× 712 3.5× 218 1.1× 75 0.5× 29 2.1k
Marcin Barylski Poland 16 103 0.2× 451 1.2× 308 1.5× 134 0.7× 39 0.2× 80 1.1k

Countries citing papers authored by Michael Pepoy

Since Specialization
Citations

This map shows the geographic impact of Michael Pepoy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Pepoy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Pepoy more than expected).

Fields of papers citing papers by Michael Pepoy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Pepoy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Pepoy. The network helps show where Michael Pepoy may publish in the future.

Co-authorship network of co-authors of Michael Pepoy

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Pepoy. A scholar is included among the top collaborators of Michael Pepoy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Pepoy. Michael Pepoy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Kennedy, David J., et al.. (2013). Diminished Antioxidant Activity of High-Density Lipoprotein-Associated Proteins in Chronic Kidney Disease. Journal of the American Heart Association. 2(2). e000104–e000104. 63 indexed citations
2.
Kennedy, David J., Yiying Fan, Yuping Wu, et al.. (2013). Plasma Ceruloplasmin, a Regulator of Nitric Oxide Activity, and Incident Cardiovascular Risk in Patients with CKD. Clinical Journal of the American Society of Nephrology. 9(3). 462–467. 20 indexed citations
3.
Kennedy, David J., W.H. Wilson Tang, Yiying Fan, et al.. (2013). Diminished Antioxidant Activity of High‐Density Lipoprotein–Associated Proteins in Chronic Kidney Disease. Journal of the American Heart Association. 2(2). 41 indexed citations
4.
Tang, W.H. Wilson, Yuping Wu, Shirley Mann, et al.. (2010). Diminished Antioxidant Activity of High-Density Lipoprotein–Associated Proteins in Systolic Heart Failure. Circulation Heart Failure. 4(1). 59–64. 56 indexed citations
5.
Tang, W.H. Wilson, Yuping Wu, Stephen J. Nicholls, et al.. (2009). Subclinical Myocardial Necrosis and Cardiovascular Risk in Stable Patients Undergoing Elective Cardiac Evaluation. Arteriosclerosis Thrombosis and Vascular Biology. 30(3). 634–640. 24 indexed citations
6.
Tang, W.H. Wilson, Kiran Philip, Stanley L. Hazen, et al.. (2005). Comparative sensitivities betweendifferent plasma B-type natriuretic peptide assays in patients with minimally symptomatic heart failure. Clinical cornerstone. 7. S18–S24. 10 indexed citations
7.
Brennan, Marie‐Luise, Marc S. Penn, Frederick Van Lente, et al.. (2004). Prognostic Value of Myeloperoxidase in Patients With Chest Pain. Obstetrical & Gynecological Survey. 59(4). 267–267. 91 indexed citations
8.
Brennan, Marie‐Luise, Marc S. Penn, Frederick Van Lente, et al.. (2003). Prognostic Value of Myeloperoxidase in Patients with Chest Pain. New England Journal of Medicine. 349(17). 1595–1604. 796 indexed citations breakdown →
9.
Lente, F Van & Michael Pepoy. (1990). Coupled-enzyme determination of catalase activity in erythrocytes. Clinical Chemistry. 36(7). 1339–1343. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026